Elhízás: ki dolgozik rajta

Intézményenként egy kártya. Szűrhetsz célpontra, országra, vagy csak az EU-13 (Horizon Europe felzárkózó) országok intézményeire.

• Minden célpont
• GLP-1 168
• PPAR 0
• FTO 0
• AMPK 3
• GIP 20
• SGLT2 5
• STAT3 0
• SIRT1 0
• PI3K 0
• NRF2 0
• AKT 0
• mTOR 2
• NLRP3 3
• MAPK 0
• TP53 0
• TNF 0
• IL-6 1
• TLR4 0
• BDNF 2
• DPP-4 1
• JNK 0
• APOE 0
• ERK 0
• IL-17 1
• PTEN 0
• STING 0
• ACE2 0
• HIF-1 0
• PCSK9 0
• VEGF 0
• IL-1 0
• JAK 0
• PNPLA3 2
• YAP 0
• HMGB1 0
• CTNNB1 0
• HER2 0
• MMP-9 0
• PD-L1 0
• PINK1 0
• TFEB 0
• TREM2 0
• CCR5 0
• FGFR 0
• GPX4 0
• IGF1R 0
• IL-23 0
• METTL3 0
• PD-1 0
• STK11 0
• AR 0
• BCL-2 0
• CFTR 0
• COX-2 0
• HDAC 0
• EGFR 0
• HSP90 0
• MEK 0
• MYC 0
• PKM2 0

Az EU-13 szűrő, nem rangsor: csak szűkíti a listát.

200+ intézményből 24, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Leállított, visszavont és felfüggesztett vizsgálatok, a szponzor által a regiszterben megadott okkal, szó szerint idézve.

• Leállították

  Small Bowel Diversion

  NCT06374368· University of Ostrava· Frissítve: 2026. nov. 6.

  “Halted for safety concerns after jejuno-colic diversion: frequent and serious late complications, incl. hepatic fibrosis, lean body mass loss and surgical reversal of the anastomosis.”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Probiotics and Insulin Resistance in Obese Asthmatics

  NCT05949255· University of Alabama at Birmingham· Frissítve: 2026. nov. 5.

  “Lost coordinator and statistician before no cost extension study could be completed.”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  The Impact of Continuous Glucose Monitoring on Glucose Variability and Weight Loss in Individuals With Prediabetes and Obesity

  NCT07423065· University of Primorska· Frissítve: 2026. nov. 4.

  “The study has been temporarily suspended pending approval from the Slovenian Agency for Medicinal Products and Medical Devices (JAZMP). The need for this additional regulatory approval was identified following communication with JAZMP.”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Physical Exercise Prehabilitation Program in mEtabolic suRgery

  NCT06889207· Flevoziekenhuis· Frissítve: 2026. okt. 30.

  “Higher dropout rate (38% versus the 10% on which the original sample size was based). Interim analysis revealed that the effect on the primary outcome measure was already highly statistically significant.”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  Molecular and Clinical Profile of Diabetes Mellitus and Its Complications

  NCT01105858· National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)· Frissítve: 2026. okt. 29.

  “Recruitment temporarily paused.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation

  NCT07677865· West China Hospital· Frissítve: 2026. okt. 16.

  “poor accrual and funding issues”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

  NCT07553299· Verdiva Bio Dev Limited· Frissítve: 2026. okt. 13.

  “The Study Sponsor made a business decision not to continue the study. The decision was not based on safety findings.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities

  NCT05532020· Soleno Therapeutics, Inc.· Frissítve: 2026. okt. 13.

  “Company Decision”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Weight Management Program for Obese Preschool Children

  NCT07126210· Peking University· Frissítve: 2026. szept. 16.

  “Study terminated prematurely due to poor accrual. The actual number of eligible children recruited from kindergartens was far lower than expected, making the study unfeasible.”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  A Food Security Intervention for the Prevention of Cancer in Low-income Families

  NCT07039630· Roswell Park Cancer Institute· Frissítve: 2026. szept. 15.

  “behavioral intervention is being prepared”A regiszter szövege, változtatás nélkül. Forrás

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

  NCT07575399· Amgen· Forrás

• A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or Obesity

  NCT07874633· Pfizer· Forrás

• Optimal Digital Weight Loss Treatment for Rural Individuals

  NCT06105957· University of South Carolina· Forrás

• A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti

  NCT03892265· Washington University School of Medicine· Forrás

• A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)

  NCT07794774· Pfizer· Forrás

• A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes

  NCT07922330· AstraZeneca· Forrás

• Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults

  NCT07388537· National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)· Forrás

• A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)

  NCT07881757· Pfizer· Forrás

• Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors

  NCT05687604· Northwestern University· Forrás

• AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  NCT07533175· Novo Nordisk A/S· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 20
• Organoids 10
• Mendelian Randomization Analysis 179
• CRISPR-Cas Systems 7
• Gene Expression Profiling 143
• Sequence Analysis, RNA 10
• Whole Genome Sequencing 4
• Exome Sequencing 19
• Proteomics 126
• Metabolomics 190
• Mass Spectrometry 28
• Flow Cytometry 16
• Immunohistochemistry 41
• Xenograft Model Antitumor Assays 15
• Positron-Emission Tomography 25
• Magnetic Resonance Imaging 254
• Machine Learning 154
• Deep Learning 20
• Cohort Studies 1008
• Genome-Wide Association Study 201

• Metabolic syndrome and liver fibrosis in nondiabetic MASLD: A cross-sectional double machine learning study.

  Medicine (Baltimore), 2026. nov.

• Machine learning predicts weight change in a real-world digital health application.

  BMC Med, 2026. okt.

• External validation and application of machine learning models for obesity in Chinese children and adolescents per Chinese and WHO growth standards.

  J Glob Health, 2026. okt.

• Predicting insulin resistance in non-diabetics: Comparing obesity indicators using machine learning.

  Medicine (Baltimore), 2026. okt.

• Association between the triacylglycerol-glucose index, TyG-BMI and hypertension in children and adolescents: a cross-sectional study with machine-learning-based risk stratification.

  Front Endocrinol (Lausanne), 2026. okt.

• Broader factors associated with current adolescent overweight/obesity status in YRBSS 2023: Survey-aware analysis and calibrated AI-assisted classification.

  PLoS One, 2026. okt.

• A machine learning-driven and explainable prediction model for in-hospital mortality in patients with diabetes mellitus and congestive heart failure: integrating XGBoost and SHAP approaches.

  Front Public Health, 2026. okt.

• Noninvasive Interstitial Glucose Estimation Using Wearables and Machine Learning in Healthy Individuals and Individuals With Obesity: Observational Cohort Study.

  JMIR Mhealth Uhealth, 2026. szept.

• Development and Validation of a Machine Learning Model for Predicting One-year Anemia After Bariatric Surgery: A Multicenter Study.

  Obes Surg, 2026. szept.

• The application of explainable machine learning for the identification of MASLD in non-obese populations.

  Front Public Health, 2026. szept.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.